Try our Advanced Search for more refined results

Durata Investor Sues To Halt $675M Actavis Deal

By Lance Duroni (October 14, 2014, 2:13 PM EDT) -- A Durata Therapeutics Inc. investor lodged a proposed class action aiming to block Actavis PLC's $675 million buyout of the infectious disease drugmaker, saying the offer shortchanges shareholders just as the company is poised to take off with the launch of its marquee drug....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!